Sliding-scale or correction-dose insulin documentation must connect a verified practitioner order, a time-specific glucose result, the dose selected from that order, the insulin actually administered, and the resident's follow-up. A generic insulin administration entry cannot explain why a variable dose was chosen.
This guide addresses documentation and software workflow, not clinical dosing. It does not provide a sample scale, glucose thresholds, or instructions to start, stop, or change insulin. It was reviewed on August 8, 2026. Adult Family Home providers should verify current Washington requirements and follow each resident's current order, assessment, care plan, delegation, pharmacy label, device instructions, and qualified professional direction.
Treat the scale as a versioned order
A correction scale is not a reusable facility template. Store it as part of the resident's authorized medication order, with:
- Resident and facility identifiers
- Insulin name, concentration, and dosage form
- Route and device
- Glucose ranges and corresponding ordered doses
- Measurement timing, such as before a named meal, when ordered
- Maximum dose or escalation instruction when stated
- Hold, call, repeat-check, meal, and special directions
- Prescriber and order source
- Written-verification attachment
- Effective date and time
- Discontinued date and time
- Order version and change history
Do not convert ranges, units, or concentrations from memory. Do not silently fill gaps or overlaps in an order. Route an unclear, incomplete, or internally conflicting direction for clarification before staff rely on it.
WAC 388-76-10475 requires an up-to-date daily medication log and documentation of medication changes, including written verification. The system should preserve the order version used for every dose so a later edit does not rewrite the past.
Keep scheduled, correction, and meal-related insulin distinct
A resident may have more than one insulin instruction active at the same time. The eMAR should show separate, clearly labeled components rather than one ambiguous total:
- Fixed scheduled dose
- Correction or sliding-scale dose
- Carbohydrate-related dose, if separately ordered
- One-time or supplemental order
- Total dose actually administered
Staff should never have to infer whether the displayed number is a component or the total. If the system calculates a total for convenience, it must still retain the source components and require the user to confirm the actual dose.
Do not merge two insulin products because both are associated with the same meal. Product, concentration, device, and order must remain visible through selection and documentation.
Verify the resident and insulin before using the scale
The administration screen should keep the resident's name, photograph when available, facility, insulin name, concentration, and device visible. A search result or previous resident selection must never carry a scale across resident boundaries.
Before staff can document a variable dose, the workflow should require them to open the active order for that resident and scheduled opportunity. It should warn when:
- The order is not yet effective or has ended
- A newer order version exists
- The glucose reading falls outside every defined range
- Two ranges overlap
- The selected product or concentration differs from the order
- The supply is expired, recalled, unavailable, or assigned to another resident
- The administration has already been recorded
An alert may prevent an unsafe selection, but software should not invent clinical instructions. The appropriate path is to display the verified order and route the user to the authorized escalation process.
Capture the glucose result as source evidence
The glucose result that supports a correction dose needs its own record. Capture:
- Result value and unit
- Measurement date and time
- Entry date and time
- Measurement method and device identifier when used by policy
- Staff member who obtained or received the result
- Whether the result was entered manually or received from an authorized integration
- Repeat result and reason, if repeated
- Relevant meal relationship when the order specifies one
- Symptoms or observations required by the resident's plan
Do not replace the original reading with a repeat. Keep both and identify which result was used to select the dose.
The CDC's blood glucose monitoring and insulin administration guidance says fingerstick devices must not be shared and insulin pens are for one person only. It also addresses cleaning shared professional-use meters, hand hygiene, and safe supply handling. The documentation flow can reinforce these controls with resident-assigned device and supply fields without presenting a checkbox as proof that safe technique occurred.
Map the reading to the exact ordered range
After a result is entered, show the matching row from the active scale in plain language. The display should include the glucose range, ordered dose, insulin, concentration, and relevant direction. Staff should confirm the row rather than retype it.
Safe software behavior includes:
- Inclusive and exclusive range boundaries represented exactly as ordered
- Units displayed beside both glucose and insulin values
- No interpolation between ranges
- No extrapolation above or below the scale
- No automatic rounding of a reading or dose
- A hard stop for missing, overlapping, or ambiguous ranges
- A visible source order and version
If no row matches, create an unresolved medication task and follow the resident-specific call or escalation direction. Do not default to zero units, the nearest range, or the prior dose.
The FDA describes medication errors as preventable events that can lead to inappropriate medication use or harm and notes that labeling and safety communications may be used to reduce them in its medication error information. Exact product and unit display matters particularly when similarly named insulin products or different concentrations are present.
Document the administration event completely
The signed administration record should connect:
- Scheduled date and time
- Glucose result used and measurement time
- Active scale row
- Correction dose selected
- Any separately ordered fixed dose
- Total dose administered
- Insulin name, concentration, device, and resident supply
- Route
- Injection site when required by policy or order
- Actual administration date and time
- Staff identity and credential context
- Second check, when required by policy
- Notes limited to relevant facts
The system should reject a signature without the actual dose. “Per sliding scale” is not enough because it does not reveal what was administered.
WAC 388-76-10470 requires the home to follow practitioner-ordered times and directions, including meal-related and bedtime directions. The screen should therefore keep timing and special directions adjacent to the dose decision.
Record non-administration without fabricating a dose
Not every scheduled opportunity ends in administration. Provide accurate outcomes such as refused, held under an order, unavailable, not administered, resident away, or other policy-defined status. The entry should capture:
- What occurred
- Glucose result, if obtained
- Reason selected from a controlled list and explanatory facts
- Resident response
- Notification or consultation
- Instructions received
- Follow-up owner and due time
Do not enter zero units as though it were an administered dose unless that representation is expressly part of the verified order and documentation policy. A non-administration outcome should remain visibly different from a completed administration.
Handle urgent or out-of-range results through the resident plan
The application may recognize that a result is outside the written scale or matches a resident-specific call instruction. It should display the exact instruction, create an acknowledgement, and start a traceable response workflow.
Record who was contacted, when, by what channel, the information provided, instructions received, and who owns the next step. If emergency services are used, connect the event to the facility's emergency and incident documentation without duplicating clinical facts in conflicting records.
Do not publish universal “low” or “high” thresholds in the facility software. Relevant thresholds and actions belong to the current resident-specific order and care plan.
Preserve corrections as amendments
If staff selected the wrong range, entered the wrong reading, or documented the wrong dose, do not overwrite the signed record. An authorized correction should preserve:
- Original reading, selection, dose, user, and timestamps
- Corrected value
- Reason and supporting evidence
- Correcting user and correction time
- Notification and follow-up
- Whether MAR, incident, inventory, and reports were updated
A correction cannot reverse medication already administered. The interface should distinguish correcting documentation from responding to an administration error. The medication error documentation guide explains the connected response workflow.
Reconcile dose, supply, and MAR history
Every administered insulin dose should reduce the appropriate resident supply using the unit of measure supported by the product and facility process. Inventory is supporting evidence, not a substitute for the MAR.
Reconciliation should identify:
- Signed doses with no supporting glucose record
- Glucose results with no resolved scheduled opportunity
- Dose outside the matched order row
- Duplicate entries for the same opportunity
- Late entries and amendments
- Missing follow-up after an escalation instruction
- Supply usage that cannot be reconciled to administrations, waste, or disposal
The MAR audit checklist provides a broader review framework. A sliding-scale audit should add order-row and glucose-to-dose matching.
Design focused insulin reports
A useful report is not a screenshot of the medication page. It should be a formatted medication report with filters for resident, facility, insulin, order version, date range, staff member, outcome, and exception status.
Show scheduled time, glucose time and value, selected range, ordered correction dose, actual dose, product, administration time, staff, exceptions, consultations, and amendments. Clearly label late-entered information and retain the report generation time.
Trend views can help authorized reviewers find documentation gaps, but they must not diagnose or recommend dosing. Export only the residents and facilities within the user's current authorization.
Test the workflow before production use
Use demonstration residents and nonclinical values to test:
- Every defined range boundary.
- A value between ranges and a value outside the scale.
- Overlapping ranges that must be blocked.
- Scheduled plus correction components.
- Two insulin products for one resident.
- A changed order effective mid-day.
- Refusal, hold, unavailable supply, and resident absence.
- Repeat glucose testing without deleting the first result.
- Duplicate administration prevention.
- Correction with complete audit history.
- Offline or interrupted entry recovery.
- Mobile display with units and resident identity always visible.
- Cross-facility access boundaries.
- Formatted MAR and exception exports.
Confirm that switching residents clears only resident-specific context, never imports another person's scale, and never loses an intentionally unsent draft without warning.
Frequently asked questions
Should the system calculate a sliding-scale insulin dose?
It may display the dose corresponding to an exact, verified order row, but staff must confirm the resident, reading, range, product, and actual dose. The software should never invent, interpolate, or extrapolate a dose.
Is “given per sliding scale” enough documentation?
No. Record the supporting glucose result, matched order row, dose actually administered, time, product, route, and staff identity.
What happens when a glucose result does not match any range?
Do not choose the nearest range. Follow the resident-specific clarification or escalation process and document the contacts, instructions, and outcome.
Can a corrected glucose value replace the original?
No. Preserve the original result and add an attributable correction or repeat result so reviewers can understand the sequence.
Should one insulin pen be used for several residents with new needles?
No. CDC guidance states that insulin pens are for one person only, even when the needle is changed.
Make the reason for every variable dose reviewable
Strong sliding-scale documentation lets an authorized reviewer follow one continuous chain: active order version, glucose evidence, matching range, selected dose, actual administration, resident response, exception handling, and amendment history.
Explore AFH Manager to connect resident-specific insulin orders, glucose results, eMAR administration, alerts, supply records, and formatted medication reports. Validate the configuration with the resident's qualified professionals and facility policy before using it for live care.